Results 211 to 220 of about 2,449,966 (235)

Liver impairment and medical management of Cushing syndrome and MACS. [PDF]

Front Endocrinol (Lausanne)
Minasyan M, Suchy W, Fedak A, Gamrat-Żmuda A, Hubalewska-Dydejczyk A, Valassi E, Gilis-Januszewska A.   +6 more
europepmc   +1 more source

Thyrotropin and growth promoting immunoglobulin (TGI) of FRTL-5 cells have no growth stimulating activity on human thyroid epithelial cell cultures [PDF]

, 1987
Bay, V., Dwenger, M., Engel, U., Fenzi, G. F., Ingbar, S. H., Mansky, T., Mckenzie, J. M., Pinchera, Aldo, Scriba, Peter Christian, Wenzel, B. E.   +9 more
core  

Impact of Meditation Device Use on Quality of Life of Patients Following Surgery for Hypercortisolism. [PDF]

J Endocr Soc
Saini J, Ferreira Taveras E, Hleibiehova Y, Bahrani Fard B, Suresh M, Sandooja R, Salama BH, Fell V, Atkinson EJ, Achenbach SJ, Bancos I.   +10 more
europepmc   +1 more source

Carney Complex: A Case Report [PDF]

, 2009
Castro, G, Coelho, L, Donato, P, Ferreira, MJ, Lourenço, C, Monteiro, P, Providência, LA, Ramos, D, Teixeira, R, Vieira, H   +9 more
core  

Prolactin-adjusted inferior petrosal sinus sampling: Pituitary and ectopic adrenocorticotropic hormone-dependent Cushing syndrome. [PDF]

J Neuroendocrinol
Sprenkeler VE, van Herwaarden AE, van de Ven AC, Kusters B, Jenniskens SFM, Netea-Maier RT, de Laat JM.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cushing's syndrome.

The Lancet, 2023
Endogenous Cushing's syndrome results from excess glucocorticoid secretion, which leads to a myriad of clinical manifestations, comorbidities, and increased mortality despite treatment.
M. Gadelha, F. Gatto, L. E. Wildemberg, M. Fleseriu   +3 more
semanticscholar   +1 more source